Michael J. LaBarre - Feb 25, 2025 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Signature
/s/ James R. Oehler, Attorney-in-Fact
Stock symbol
HALO
Transactions as of
Feb 25, 2025
Transactions value $
-$1,260,681
Form type
4
Date filed
2/27/2025, 06:32 PM
Previous filing
Feb 24, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Sale -$539K -9.3K -4.76% $58.01 186K Feb 25, 2025 Direct F1, F2
transaction HALO Common Stock Sale -$41.1K -700 -0.38% $58.67 185K Feb 25, 2025 Direct F1, F3
transaction HALO Common Stock Sale -$546K -9.4K -5.07% $58.09 176K Feb 26, 2025 Direct F1, F4
transaction HALO Common Stock Sale -$35.2K -600 -0.34% $58.65 175K Feb 26, 2025 Direct F1, F5
transaction HALO Common Stock Sale -$93K -1.6K -0.91% $58.25 174K Feb 27, 2025 Direct F1, F6
transaction HALO Common Stock Sale -$5.87K -100 -0.06% $58.74 174K Feb 27, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on September 18, 2024.
F2 Represents a weighted average sales price per share. These shares were sold at prices ranging from $57.54 to $58.47. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3 Represents a weighted average sales price per share. These shares were sold at prices ranging from $58.54 to $58.91. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4 Represents a weighted average sales price per share. These shares were sold at prices ranging from $57.62 to $58.61. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F5 Represents a weighted average sales price per share. These shares were sold at prices ranging from $58.62 to $58.68. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F6 Represents a weighted average sales price per share. These shares were sold at prices ranging from $57.71 to $58.66. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.